From Discovery to Delivery

Innovation in medicine does not fail because of a lack of ideas. It struggles in the space between discovery and delivery, where promising science must navigate complexity, stakeholders, and real-world constraints. Understanding that journey is what transforms innovation into impact.

At Eureka, participants begin to see translational medicine not as a linear pipeline, but as a connected system — one that requires clarity, coordination, and intent.

Seeing the full pathway

Adrian Luo Xuxin

“I gained a much clearer understanding of how the different parts of drug discovery connect.”

For Adrian Luo Xuxin, the shift began with visibility. Before Eureka, the drug discovery process could feel fragmented: different stages, different actors, different priorities. Through the Program, those pieces came together into a coherent picture.

What emerged was an understanding of:

• how early research informs later development

• where decisions shape outcomes

• and how different disciplines intersect along the way

This broader view changes how work is approached. Decisions are made with awareness of downstream consequences and opportunities.

Thinking in pipelines, not projects

Charissa Goh

“The course helped me think about how research translates into real endpoints.”

For Charissa Goh, the key shift was practical. Innovation is often framed around discovery, but progress depends on what happens next. Eureka introduced a way of thinking that connects:

• scientific insight

• clinical relevance

• and implementation in the real world

It encouraged a move away from isolated projects toward pipeline thinking. This means:

• defining clear endpoints early

• aligning research with clinical needs

• and considering feasibility from the outset

The result is work that is rigorous yet directional and actionable.

From breakthrough to real-world application

Gu Qinglong

“Translational medicine is about ensuring discoveries reach the patients who need them.”

Gu Qinglong’s experience highlights the full ambition of translational work. Breakthroughs in science carry potential, but potential alone does not change outcomes. The real challenge lies in:

• bridging research and clinical application

• navigating regulatory and development pathways

• and ensuring accessibility to patients

At Eureka, this journey is made visible. Participants begin to understand that innovation requires scientific excellence, strategic thinking, and sustained collaboration across sectors. It is not a single breakthrough that defines success, it is the ability to carry that breakthrough all the way through the system.

Closing

Innovation does not end at discovery. It unfolds through a series of decisions, connections, and transitions — each shaping whether an idea reaches the people it was meant to serve.

Eureka equips innovators with more than knowledge of the system. It builds the ability to:

• see the full pathway

• navigate complexity with intention

• and move ideas forward with clarity

Because in translational medicine, progress is defined not by what is discovered, but by what is delivered.